W
Weiguo Xiao
Researcher at China Medical University (PRC)
Publications - Â 15
Citations - Â 248
Weiguo Xiao is an academic researcher from China Medical University (PRC). The author has contributed to research in topics: Rheumatoid arthritis & Lupus nephritis. The author has an hindex of 8, co-authored 15 publications receiving 175 citations.
Papers
More filters
Journal ArticleDOI
Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis.
TL;DR: It was found that skin ulceration, CRP, serum ferritin, anti-MDA5 Ab, and lymphocytopenia were significantly associated with ILD, and Multivariate logistic regression analysis indicated that anti-mda5 Ab+, elevatedCRP, and decreased counts of lymphocyte were independent risk factors for RP-ILD, which can provide a precise predict forRP-ILD in CADM patients.
Journal ArticleDOI
Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort
Xinyao Wu,Min Yang,Yue-Sheng Xie,Weiguo Xiao,Jin Lin,Bin Zhou,Guan Xin,Cai-Nan Luo,Nan Che,Xing-Zhen Liu,Chao Wang,Jialin Teng,Xiaobing Cheng,Junna Ye,Yutong Su,Hui Shi,Yufeng Yin,Mengru Liu,Yue Sun,Qiongyi Hu,Zhuochao Zhou,Huihui Chi,Yi Liu,Xiao Zhang,Jinwei Chen,Miaojia Zhang,Dongbao Zhao,Chengde Yang,Lijun Wu,Honglei Liu +29 more
TL;DR: Infection emerged as the foremost risk factor for mortality, followed by lupus encephalopathy, however, l upus nephritis and hematological abnormalities occurred more frequently in survival patients, suggesting SLE patients at a younger age of diagnosis have a poorer prognosis.
Journal ArticleDOI
Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis
TL;DR: It is demonstrated that stimulated PBMCs from DM and PM patients produce increased levels of IL-23 as compared to HC, providing further evidence that IL-17/IL-23 may play a crucial role in autoimmune diseases.
Journal ArticleDOI
Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study
Huaqun Zhu,Huaqun Zhu,Ru Li,Ru Li,Zhanyun Da,Liqi Bi,Xiang-Pei Li,Yang Li,Chongyang Liu,Fengxiao Zhang,Zhijun Li,Xiangyuan Liu,Zhiyi Zhang,Lingyun Sun,Y Wang,Wei Zhang,Quan Jiang,Jinwei Chen,Qing-Ping Chen,Zhen-Bin Li,Lijun Wu,Wencheng Qi,Jianhua Xu,Xiangjun Cui,Xiaofei Wang,Long Li,Xiaomei Leng,Guochun Wang,Dongbao Zhao,Lindi Jiang,Dongyi He,Xiaomin Liu,Ling Li,Yongfei Fang,Cibo Huang,Huaxiang Wu,Shaoxian Hu,Qin Li,Hui Song,Weiguo Xiao,Lu Gong,Liaojia Zhang,X Li,Zhanguo Li,Zhanguo Li,Yin Su,Yin Su +46 more
TL;DR: The remission rate of RA disease activity, as assessed in Chinese clinical practice, was very low and adverse effects of the medicine occurred in approximately one in five RA patients, with bDMARDs demonstrated to be the medication with the lowest side effects.
Journal ArticleDOI
CTGF promotes articular damage by increased proliferation of fibroblast-like synoviocytes in rheumatoid arthritis
TL;DR: The findings indicate that CTGF plays a crucial role in the proliferation of FLS in RA and probably contributes to synovial lining cell hyperplasia and eventually to joint destruction in patients with RA.